Roivant Sciences(ROIV) - 2023 Q2 - Earnings Call Presentation
Roivant Sciences(ROIV)2023-11-14 03:26
November 13, 2023 Matthew Gline Chief Executive Officer Richard Pulik Chief Financial Officer Frank Torti, MD Vant Chair Eric Venker, MD, PharmD President and Chief Operating Officer Mayukh Sukhatme, MD President and Chief Investment Officer Forward-Looking Statements This presentation includes forward-looking statements that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. All statements other than st ...